{"id":9335,"date":"2016-07-15T07:05:47","date_gmt":"2016-07-15T07:05:47","guid":{"rendered":"http:\/\/revoscience.com\/en\/?p=9335"},"modified":"2016-07-15T07:11:10","modified_gmt":"2016-07-15T07:11:10","slug":"juno-therapeutics-cancer-drug-trial-allowed-to-continue","status":"publish","type":"post","link":"https:\/\/www.revoscience.com\/en\/juno-therapeutics-cancer-drug-trial-allowed-to-continue\/","title":{"rendered":"Juno Therapeutics Cancer Drug Trial Allowed to Continue"},"content":{"rendered":"<div class=\"panel-pane pane-entity-field pane-node-field-body-paragraphs\">\n<div class=\"pane-content\">\n<div class=\"paragraphs-items paragraphs-items-field-body-paragraphs paragraphs-items-field-body-paragraphs-full paragraphs-items-full\">\n<div class=\"field field-name-field-body-paragraphs field-type-paragraphs field-label-hidden\">\n<div class=\"field-items\">\n<div class=\"field-item odd\">\n<div class=\"entity entity-paragraphs-item paragraphs-item-embedded-text\" style=\"font-weight: normal;\">\n<div class=\"content\">\n<div class=\"field field-name-field-embedded-text field-type-text-long field-label-hidden\">\n<div class=\"field-items\">\n<div class=\"field-item even\">\n<figure id=\"attachment_9336\" aria-describedby=\"caption-attachment-9336\" style=\"width: 800px\" class=\"wp-caption alignnone\"><a href=\"http:\/\/revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9336\" src=\"http:\/\/revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg\" alt=\"T cells attacking cancer cell\" width=\"800\" height=\"560\" title=\"\" srcset=\"https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg 800w, https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713-300x210.jpg 300w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/a><figcaption id=\"caption-attachment-9336\" class=\"wp-caption-text\">T cells attacking cancer cell<\/figcaption><\/figure>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">A CAR-T therapy trial by Juno Therapeutics that was halted in this July following the death of three patients has been allowed to resume, the company announced.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">This July he U.S. Food and Drug Administration\u00a0<a style=\"color: inherit;\" href=\"http:\/\/www.dddmag.com\/news\/2016\/07\/study-promising-cancer-therapy-halted-due-deaths\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">abruptly halted<\/span><\/a>\u00a0Juno\u2019s clinical trial of an experimental treatment for leukemia after three patients died from swelling in the brain. The company said the deaths resulted not from the genetically engineered treatment but from fludarabine, a second chemotherapy drug used in its pre-treatment regimen. The FDA said the trial can continue if this chemotherapy drug is no longer used in the regimen.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Juno\u2019s initial studies used only one chemotherapy drug, cyclophosphamide, to prime the immune system for the therapy.<\/span><\/p>\n<p style=\"text-align: justify;\">[pullquote]Although the treatment is still unproven, CAR-T therapy has shown successful results in treating leukemia and lymphoma.[\/pullquote]<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">CAR-T therapy involves extracting patients\u2019 immune system T cells, genetically engineering them to target cancer cells, and infusing them back into the bloodstream.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Although the treatment is still unproven, CAR-T therapy has shown successful results in treating leukemia and lymphoma.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">But CAR-T therapy can cause severe side effects, such as swelling in the brain and cytokine-release syndrome, a condition in which the infused T cells release a rapid amount of cytokines into the bloodstream, which can lead to dangerously high fevers and precipitous drops in blood pressure.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Juno\u2019s therapy, known as JCAR015, is in mid-stage testing, with 20 patients currently enrolled in the study.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\">Juno executives say they expect the therapy\u2019s first approval to be in 2018. The company is competing against Kite Pharma and Novartis, all of which are racing to bring the first CAR-T therapy to market.<\/span><\/p>\n<p style=\"text-align: justify;\">Source: <a href=\"http:\/\/www.dddmag.com\/news\/2016\/07\/juno-therapeutics-cancer-drug-trial-allowed-continue?et_cid=5390146&amp;et_rid=423855790&amp;type=image&amp;et_cid=5390146&amp;et_rid=423855790&amp;linkid=http%3a%2f%2fwww.dddmag.com%2fnews%2f2016%2f07%2fjuno-therapeutics-cancer-drug-trial-allowed-continue%3fet_cid%3d5390146%26et_rid%3d%%subscriberid%%%26type%3dimage\" target=\"_blank\" rel=\"noopener\">dddmag.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A CAR-T therapy trial by Juno Therapeutics that was halted in this July following the death of three patients has been allowed to resume, the company announced.<\/p>\n","protected":false},"author":6,"featured_media":9336,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,17],"tags":[],"class_list":["post-9335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine","category-research"],"featured_image_urls":{"full":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",800,560,false],"thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713-150x150.jpg",150,150,true],"medium":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713-300x210.jpg",300,210,true],"medium_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",750,525,false],"large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",750,525,false],"1536x1536":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",800,560,false],"2048x2048":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",800,560,false],"ultp_layout_landscape_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",800,560,false],"ultp_layout_landscape":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",800,560,false],"ultp_layout_portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",600,420,false],"ultp_layout_square":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",600,420,false],"newspaper-x-single-post":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",700,490,false],"newspaper-x-recent-post-big":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",514,360,false],"newspaper-x-recent-post-list-image":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",93,65,false],"web-stories-poster-portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",640,448,false],"web-stories-publisher-logo":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",96,67,false],"web-stories-thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/shutterstock_313800713.jpg",150,105,false]},"author_info":{"info":["Amrita Tuladhar"]},"category_info":"<a href=\"https:\/\/www.revoscience.com\/en\/category\/health\/medicine\/\" rel=\"category tag\">Medicine<\/a> <a href=\"https:\/\/www.revoscience.com\/en\/category\/news\/research\/\" rel=\"category tag\">Research<\/a>","tag_info":"Research","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/9335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/comments?post=9335"}],"version-history":[{"count":0,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/9335\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media\/9336"}],"wp:attachment":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media?parent=9335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/categories?post=9335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/tags?post=9335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}